Evidence map›Paper›PMID 41793477›Full record

ArticleAnnals of hematology2026

Risk factors for venous thromboembolism in newly diagnosed multiple myeloma patients based on thrombosis prophylaxis.

Sen Zhao, Yini Wang, Jing Jia, Qiling Bu, Wenming Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sen ZhaoDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Yini WangDepartment of Hematology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jing JiaDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Qiling BuDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Wenming ChenDepartment of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. wenming_chen-bj@outlook.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to explore risk factors for symptomatic venous thromboembolism (VTE) in newly diagnosed multiple myeloma (NDMM) patients, with particular focus on the moderating effect of age. A retrospective case-control study was conducted, and clinical and laboratory data from 309 NDMM patients were analyzed. Multivariable logistic regression and interaction analysis were employed to identify independent risk factors and assess age as an effect modifier. Age (OR = 1.060, 95% CI: 1.019-1.102), immobilization ≥ 72 h (OR = 2.835, 95% CI: 1.207-6.662), elevated D-dimer (> 0.55 mg/L) (OR = 2.294, 95% CI: 1.161-4.532), estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m

Indexed as

Multiple MyelomaVenous ThromboembolismAdultAgedAged, 80 and overAge FactorsAntineoplastic Combined Chemotherapy ProtocolsCase-Control StudiesCyclophosphamideDexamethasoneDoxorubicinFemaleFibrin Fibrinogen Degradation ProductsHumansMaleMiddle AgedCyclophosphamideDexamethasoneDoxorubicinFibrin Fibrinogen Degradation Productsfibrin fragment DAgeImmunomodulatorsNewly diagnosed multiple myelomaRenal insufficiencyVenous thromboembolism

Identifiers

PMID41793477
PMCPMC12967562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.